PET scans with disease-specific tracers (e.g., amyloid or tau in AD) offer high specificity, while MRI and CT have moderate specificity, as structural changes may overlap with conditions like vascular dementia or aging (Lee et al. 2024). The gene discussed is MAPT; the disease is Alzheimer disease.